EUVIMEDEUVIMED entdecken
Crossref

Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models

Chunwei Mo, Jian-Er Tan, Meilian Zhang, Zihao Chen, Yun Zhu, Yanjiang Han, Meng Wang, Ye Dong, Baomin Xi, Ganghua Tang iD, Penghui Sun iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Chunwei Mo und 10 weiteren Autor:innen. Beteiligte Einrichtung: GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical U…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Fluorine Radioisotopes, Radiopharmaceuticals, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Medical Research Foundation, President Foundation of Nanfang Hospital, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PD-L1 in the immune checkpoint pathway is expressed on various tumor cells, and multiple PD-1/PD-L1 inhibitors have been approved for treating these malignancies. However, clinical studies indicate that only 20-30% of patients benefit from immunotherapy. To address this problem, two novel peptide-based radiotracers, [18F]AlF-WT12 and [18F]AlF-IPB-WT12, were developed within the present study. Both tracers were successfully prepared, with radiochemical yields of 15-25% and 25-35%, respectively (n > 5), and both exhibited high molar activities (17.97-30.11 GBq/μmol and 18.09-26.46 GBq/μmol, respectively). Their evaluation using in vivo PET imaging demonstrated significantly higher accumulation of both tracers in PD-L1-expressing 4T1-hPD-L1 and A549-hPD-L1 tumors compared to CHO control tumors. Notably, the [18F]AlF-IPB-WT12 exhibited superior tumor uptake and prolonged retention time relative to [18F]AlF-WT12. Additionally, good correlations were obtained between the PET imaging results and the results obtained from biodistribution studies and immunohistochemistry studies. Together, our findings demonstrate the promise of [18F]AlF-IPB-WT12 as a tracer for noninvasive tumor imaging in clinical settings, with potential to guide immunotherapy decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenFluorine RadioisotopesRadiopharmaceuticalsPeptidesNeoplasmsAnimalsMiceHumansPositron-Emission TomographyTissue DistributionCell Line, TumorFemaleMice, Inbred BALB CCricetulusA549 CellsCHO Cells

Stichwörter der Autor:innen

PD-L1PET/CTWT12[18F]AlF labelingtumor imaging

Substanzen

B7-H1 AntigenFluorine RadioisotopesRadiopharmaceuticalsPeptidesCD274 protein, humanFluorine-18

Autor:innen und Institutionen

  • GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China.
  • Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Liver Tumor Center, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.

ORCID-Profile: Ganghua Tang, Penghui Sun

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangdong Medical Research Foundation
  • President Foundation of Nanfang Hospital, Southern Medical University
  • Guangzhou Key Research and Development Program on Agriculture and Social Development Science
  • Medical Products Administration of Guangdong Province

Zitieren

APA

Mo, C., Tan, J. E., Zhang, M., Chen, Z., Zhu, Y., Han, Y., Wang, M., Dong, Y., Xi, B., Tang, G., & Sun, P. (2025). Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01032

Vancouver

Mo C, Tan JE, Zhang M, Chen Z, Zhu Y, Han Y, et al. Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01032

BibTeX
@article{Mo2025,
  author = {Mo, Chunwei and Tan, Jian-Er and Zhang, Meilian and Chen, Zihao and Zhu, Yun and Han, Yanjiang and Wang, Meng and Dong, Ye and Xi, Baomin and Tang, Ganghua and Sun, Penghui},
  title = {Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01032}
}
Kostenlos starten →